NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Anemic cancer patients undergoing chemotherapy
Date of first enrollment	01/09/2005
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : recombinant human erythropoietin INN of investigational material : Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : Subcutaneous injection

Outcome(s)

Primary Outcome	The increase in Hb concentration
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	Not applicable
Gender	Both
Include criteria	Anemic cancer patients undergoing chemotherapy
Exclude criteria